Chlorpyrifos (CPF) has been shown to have male reproductive toxicity in mice and rat. However, the association of CPF and male reproduction in pigs remains unknown. Therefore, this study attempts to investigate the damage of CPF on male reproduction in pigs and its potential molecular mechanisms. First, ST cells and porcine sperms were treated with CPF and then cell proliferation, apoptosis, motility of sperm, and oxidative stress levels were examined, respectively. Meanwhile, RNA sequencing was performed on ST cells before and after the treatment of CPF. The results of experiments showed that CPF had broad-spectrum toxic effects on ST cells and porcine sperms. The RNA-sequencing data and WB results indicated that CPF may regulate cell survival through the PI3K-AKT pathway. In conclusion, this study may lay the foundation for improving male fertility in pigs and provide theoretical information for human infertility.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214306 | PMC |
| http://dx.doi.org/10.1016/j.isci.2023.106558 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A prospective cohort of treatment-seeking patients with problematic use of prescription narcotic drugs: study protocol and baseline characteristics.
BMC Psychiatry
December 2024
The Stockholm Centre for Dependency Disorders, Stockholm Health Care Services, Region Stockholm, Friskvårdsvägen 4, Stockholm, 112 81, Sweden.
Background: There is limited knowledge on long-term outcomes of tapering treatment for individuals with problematic use of prescription narcotics, including opioids and benzodiazepines. The overall aim of the study is to investigate clinical trajectories and treatment outcomes of patients seeking treatment in addiction care.
Methods: This paper presents the study protocol and baseline characteristics of a cohort of patients seeking treatment for problematic use of prescription narcotic drugs at specialized outpatient addiction services.
Chlorpyrifos intermittent exposure enhances cardiovascular but not behavioural responses to contextual fear conditioning in adult rats: Possible involvement of brain oxidative-nitrosative stress.
Behav Brain Res
February 2025
Pharmaceutical Sciences Graduate Program, Health Sciences Centre, Federal University of Espírito Santo, Vitória, ES, Brazil; Department of Pharmaceutical Sciences, Health Science Centre, Federal University of Espírito Santo, Vitória, ES, Brazil. Electronic address:
Article Synopsis
- Exposure to organophosphorus compounds, like chlorpyrifos (CPF), can lead to various health issues affecting the brain and heart, primarily due to the inhibition of the enzyme acetylcholinesterase (AChE).
- In a study on rats, intermittent CPF treatment was found to increase anxiety and impair motor functions, but it did not significantly affect depression symptoms or fear responses after a washout period.
- Measurement of AChE activity showed significant reductions in key brain areas, indicating a link between CPF exposure and neurotoxicity, particularly at higher doses.
Cardiac Papillary Fibroelastoma and Cerebrovascular Events: A Systematic Review.
CJC Open
November 2024
Department of Cardiology, Memorial Healthcare System, Florida, USA.
Background: Cardiac papillary fibroelastomas (CPFs) are benign endocardial tumours with embolic potential. This article is a systematic review to identify the clinical profile, diagnosis, tumour characteristics, and treatment modalities in patients with CPF presenting with stroke or transient ischemic attack (TIA).
Methods: This systematic review was conducted using the PubMed and Embase databases, including case reports and/or series and observational studies (for a search period of up until April 2022).
Impacts of an organophosphate pesticide and water restriction on physiology and immunity in the passerine Zonotrichia capensis.
Comp Biochem Physiol C Toxicol Pharmacol
February 2025
Departamento de Ciencias Ecológicas, Facultad de Ciencias, Universidad de Chile, Casilla, 653, Santiago, Chile; Center of Applied Ecology and Sustainability (CAPES), Santiago, Chile; Millennium Institute for Integrative Biology (iBio), Santiago, Chile; Milennium Nucleus of Patagonian Limit of Life (LiLi), Valdivia, Chile. Electronic address:
Climate change, specifically rising temperatures and increased frequency of droughts will increase the level of exposure of organisms to chemical pollution. Notably, the impact of increased frequency and duration of drought events and subsequent dehydration on pesticide toxicity remains largely unknown. We evaluated the combined effects of exposure to the pesticide Chlorpyrifos (CPF) and water restriction (WR) on the enzymatic activities of three plasma esterases (acetylcholinesterase, butyrylcholinesterase and carboxylesterase), basal metabolic rate (BMR), leukocyte profile (proportion of heterophils to lymphocytes; H:L ratio), and bactericidal capacity of plasma in the rufous-collared sparrow (Zonotrichia capensis), a common passerine bird in Chile.
View Article and Find Full Text PDFGlofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial.
Lancet
November 2024
School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia.
Background: Glofitamab monotherapy induces durable remission in patients with relapsed or refractory diffuse large B-cell lymphoma after two or more previous therapies, but has not previously been assessed as a second-line therapy. We investigated the efficacy and safety of glofitamab plus gemcitabine-oxaliplatin (Glofit-GemOx) versus rituximab (R)-GemOx in patients with relapsed or refractory diffuse large B-cell lymphoma.
Methods: The phase 3, randomised, open-label STARGLO trial was done at 62 centres in 13 countries in Asia and Australia, Europe, and North America.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!